NCT00850421View on ClinicalTrials.gov

Pilot Study of BOTOX for Migraine Headaches

NATerminatedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Migraine Headache
Interventions
DRUG

Botulinum Toxin Type A

100 Units - Dilution: 25U/ml (4:1 BOTOX/preservative free saline)

Trial Locations (1)

55426

Park Nicollet Health Services, Minneapolis

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

HealthPartners Institute

OTHER